Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma
Qian Wang,Chunwei Xu,Wenxian Wang,Yongchang Zhang,Ziming Li,Zhengbo Song,Jiandong Wang,Jinpu Yu,Jingjing Liu,Shirong Zhang,Xiuyu Cai,Wen Li,Ping Zhan,Hongbing Liu,Tangfeng Lv,Liyun Miao,Lingfeng Min,Jiancheng Li,Baogang Liu,Jingping Yuan,Zhansheng Jiang,Gen Lin,Xiaohui Chen,Xingxiang Pu,Chuangzhou Rao,Dongqing Lv,Zongyang Yu,Xiaoyan Li,Chuanhao Tang,Chengzhi Zhou,Junping Zhang,Hui Guo,Qian Chu,Rui Meng,Xuewen Liu,Jingxun Wu,Xiao Hu,Jin Zhou,Zhengfei Zhu,Xiaofeng Chen,Weiwei Pan,Fei Pang,Wenpan Zhang,Qijie Jian,Kai Wang,Liping Wang,Youcai Zhu,Guocai Yang,Xinqing Lin,Jing Cai,Huijing Feng,Lin Wang,Yingying Du,Wang Yao,Xuefei Shi,Xiaomin Niu,Dongmei Yuan,Yanwen Yao,Jianhui Huang,Xiaomin Wang,Yinbin Zhang,Pingli Sun,Hong Wang,Mingxiang Ye,Dong Wang,Zhaofeng Wang,Yue Hao,Zhen Wang,Bing Wan,Donglai Lv,Jianwei Yu,Jin Kang,Jiatao Zhang,Chao Zhang,Lixin Wu,Lin Shi,Leiguang Ye,Gaoming Wang,Yina Wang,Feng Gao,Jianfei Huang,Guifang Wang,Jianguo Wei,Long Huang,Bihui Li,Zhang Zhang,Zhongwu Li,Yueping Liu,Yuan Li,Zhefeng Liu,Nong Yang,Lin Wu,Qiming Wang,Wenbin Huang,Zhuan Hong,Guansong Wang,Fengli Qu,Meiyu Fang,Yong Fang,Xixu Zhu,Kaiqi Du,Jiansong Ji,Yi Shen,Jing Chen,Yiping Zhang,Shenglin Ma,Yuanzhi Lu,Yong Song,Anwen Liu,Wenzhao Zhong,Wenfeng Fang
DOI: https://doi.org/10.1111/1759-7714.15022
IF: 3.223
2023-07-19
Thoracic Cancer
Abstract:Screening, diagnosis, treatment and follow‐up of malignant pleural mesothelioma. Malignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and its incidence has been increasing in recent years. Due to the insidious onset and strong local invasiveness of MPM, most patients are diagnosed in the late stage and early screening and treatment for high‐risk populations are crucial. The treatment of MPM mainly includes surgery, chemotherapy, and radiotherapy. Immunotherapy and electric field therapy have also been applied, leading to further improvements in patient survival. The Mesothelioma Group of the Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) developed a national consensus on the clinical diagnosis and treatment of MPM based on existing clinical research evidence and the opinions of national experts. This consensus aims to promote the homogenization and standardization of MPM diagnosis and treatment in China, covering epidemiology, diagnosis, treatment, and follow‐up.
oncology,respiratory system